Category: News

Antoxerene closes $1.5M for drug discovery in pathways of aging

Written by Welcome on August 23, 2017

LAFAYETTE, NY: Today, Antoxerene, a pharmaceutical company that develops small molecule drugs for pathways of aging, announced the closing of an oversubscribed $1.5M seed round. Michael Greve‚Äôs Kizoo Technology Capital, SENS Research Foundation, and private investors participated in the round. Drug screening is commonly performed in the life sciences to identify leads for drug development. […]